Amryt Pharma’s Acquisition of Chiasma

Goodwin Procter LLP advised Chiasma, Inc. on the deal.Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM: AMYT)…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now